FR EA

Matter 1018-00002 — Penterra Pharmaceuticals Corp

2023 · 12 documents · M&A / Corporate · D. Lindqvist

39.4hours logged
$5,400unbilled WIP
$36,000billed to date
DateLawyerDescription HoursAmount
2025-04-13 L. Marchetti Correspondence re matter closing memo 3.5 $3,675
2025-04-20 C. Fontaine Review and annotate corrective dhcp letter 1.2 $1,260
2025-04-27 J. Whitfield Conference call re draft fda response letter 1.2 $1,260
2025-04-25 J. Whitfield Conference call re fda extension request letter 2.5 $2,625
2025-05-03 E. Alder Analyze co counsel engagement letter whitfield bauer 0.5 $525
2025-05-28 E. Alder Review and annotate engagement letter penterra 2.6 $2,730
2025-05-25 A. Nakamura Conference call re internal investigation plan memo 0.6 $630
2025-05-18 C. Fontaine Prepare privilege work product protocol memo 3.4 $3,570
2025-05-07 D. Lindqvist Draft and revise internal investigation findings memo 1.4 $1,470
2025-05-10 S. Beaumont Conference call re preliminary assessment memo 3.2 $3,360
2025-06-12 A. Nakamura Correspondence re promotional labeling compliance memo 1.4 $1,470
2025-06-29 R. Okafor Conference call re securities disclosure advice memo 0.7 $735
Invoice preview 39.4 $5,400